The statement that “mutations in gene X cause disease Y” is a hypothesis to be tested, not a statement of fact. For inherited diseases such as retinal dystrophies, one substantiating piece of evidence is the presence of a putative disease-causing mutation in more than one family with the same disease. In this issue, Arno et al.[1] provide an instructive example of a possible flaw in this argument: if all affected families share the same mutation, then the mutation may have arisen in a shared, common ancestor and, therefore, another mutation physically close to the hypothetical cause may be the actual cause. A shared mutation arising from a common ancestor is a founder mutation, and variants close to the mutation are in linkage disequilibrium with each other. Even for mutations that arose many generations ago, the region of linkage disequilibrium is hundreds-of-thousands of base pairs in length, encompassing many genes. Arno et al.[1] report next-generation sequencing in families with inherited retinal dystrophies; among the families, six have a homozygous mutation in the RGR gene on chromosome 10q, which codes for an RPE-specific G protein-coupled receptor. The RGR mutation, Ser66Arg, was first reported by Morimura et al.[2] as the probable cause of disease in one of the families. However, Arno et al.[1] also found a frame shift mutation in a nearby gene, CDHR1, a gene previously associated with recessive rod–cone dystrophy.[3,4] Based on several lines of evidence, the CDHR1 mutation is the probable cause of disease in these families and the RGR mutation is a rare, benign variant in linkage disequilibrium. This brings into question whether mutations in RGR do, in fact, cause recessive retinal disease, and suggests that other one-off mutations may not be pathogenic, in spite of published reports to the contrary.
Authors: Robert H Henderson; Zheng Li; Mai M Abd El Aziz; Donna S Mackay; Mohammad A Eljinini; Marwan Zeidan; Anthony T Moore; Shomi S Bhattacharya; Andrew R Webster Journal: Mol Vis Date: 2010-01-15 Impact factor: 2.367
Authors: Gavin Arno; Sarah Hull; Keren Carss; Arundhati Dev-Borman; Christina Chakarova; Kinga Bujakowska; L Ingeborgh van den Born; Anthony G Robson; Graham E Holder; Michel Michaelides; Frans P M Cremers; Eric Pierce; F Lucy Raymond; Anthony T Moore; Andrew R Webster Journal: Invest Ophthalmol Vis Sci Date: 2016-09-01 Impact factor: 4.799